1
|
Yavuz O, Kurt S, Ozmen S, Bilen E, Akdöner A. Prediction of Intraperitoneal Adhesions in Repeated Cesarean Deliveries with Stria Gravidarum Scoring System: A Cross-sectional Study. Niger J Clin Pract 2024; 27:489-495. [PMID: 38679772 DOI: 10.4103/njcp.njcp_767_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2023] [Accepted: 03/01/2024] [Indexed: 05/01/2024]
Abstract
BACKGROUND The preoperative prediction of intraperitoneal adhesion (IPA) before repeated cesarean deliveries (CD), which are becoming more prevalent, is crucial for maternal health. AIM The aim of the study was to preoperatively predict IPA in repeated CD with the stria gravidarum (SG) scoring system. METHODS A total of 167 patients with at least one previous CD at or beyond 37 weeks of gestation were analyzed. Preoperative SG was calculated according to the Davey scoring system: 0-2 score were defined as mild SG (Group 1; n: 94, 56.2%), and 3-8 score were defined as severe SG (Group 2; n = 73, 43.8%). Preoperative previous cesarean incision features were evaluated according to the Vancouver scar scale. IPA was evaluated according to the Nair's and modified Nair's scoring systems. RESULTS Parity, younger age at first pregnancy, higher body mass index, number of previous CDs, rate of scar symptoms, Nair's and the modified Nair's scores were statistically significant in Group 2 (P = 0.01; P = 0.04; P = 0.007; P = 0.004; P < 0.001; P = 0.007; P = 0.02, respectively). Davey score ≥3 and Vancouver score ≥4.5 were determined as the cut-off value to predict IPA (P = 0.1 and 0.07, respectively). According to multivariate analysis, both Davey and Vancouver scores are independent factors in predicting IPA (P = 0.02 and 0.04, respectively). CONCLUSION Evaluating the SG score through the Davey score in women with a history of previous CD may assist in predicting IPA status before the planning of a subsequent surgery.
Collapse
Affiliation(s)
- O Yavuz
- Department of Gynecology and Obstetrics, Dokuz Eylul University School of Medicine, Izmir, Turkey
| | - S Kurt
- Department of Gynecology and Obstetrics, Dokuz Eylul University School of Medicine, Izmir, Turkey
| | - S Ozmen
- Department of Gynecology and Obstetrics, T.C. Sağlık Bakanlığı Karacabey Devlet Hastanesi, Bursa, Turkey
| | - E Bilen
- Department of Gynecology and Obstetrics, Dokuz Eylul University School of Medicine, Izmir, Turkey
| | - A Akdöner
- Department of Gynecology and Obstetrics, Dokuz Eylul University School of Medicine, Izmir, Turkey
| |
Collapse
|
2
|
Işıkdoğan A, Akdeniz N, Küçüköner M, Kaplan M, Urakçı Z, Karhan O, Sezgin Y, Bilen E, Ebinç S, Teke F, Laçin Ş, Alan O, Ercelep O, Yumuk F. Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz259.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
3
|
Esin E, Oksuzoglu B, Bilici A, Cicin I, Kostek O, Kaplan MA, Aksoy S, Aktas BY, Ozdemir O, Alacacioglu A, Cabuk D, Sumbul AT, Sakin A, Paydas S, Yetisir E, Er O, Korkmaz T, Yildirim N, Sakalar T, Demir H, Artac M, Karaagac M, Harputluoglu H, Bilen E, Erdur E, Degirmencioglu S, Aliyev A, Cil T, Olgun P, Basaran G, Gumusay O, Demir A, Tanrikulu E, Yumuk PF, Imamoglu I, Oyan B, Cetin B, Haksoyler V, Karadurmus N, Erturk I, Evrensel T, Yilmaz H, Beypinar I, Kocer M, Pilanci KN, Seker M, Urun Y, Yildirim N, Eren T, Demirci U. Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes. Cancer Chemother Pharmacol 2018; 83:131-143. [PMID: 30377778 DOI: 10.1007/s00280-018-3712-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2018] [Accepted: 10/25/2018] [Indexed: 01/19/2023]
Abstract
PURPOSE In this study, we aimed to describe the real-life practice outcomes of pertuzumab-trastuzumab-taxane (PTT) combination in visceral organ metastatic, trastuzumab-naive breast cancer (BC) patients. METHODS This study was conducted by Turkish Oncology Group and included 317 patients' data from 36 centers. RESULTS Median age was 51 (22-82). Median PFS was 28.5 months, while median OS was 40.3 months. Patients with brain metastases (n: 13, 4.1%) had worse PFS (16.8 m vs. 28.5 m; p = 0.002) and OS (26.7 m vs. 40.3 m; p = 0.009). Patients older than 65 years of age (n: 42, 13.2%) had significantly lower OS results (19.8 m vs. 40.3 m; p = 0.01). Two hundred sixty-eight patients (86.7%) received docetaxel while 37 patients (11.7%) received paclitaxel. PFS and OS were similar between taxane groups. In eight patients (2.5%), 5-40% ejection fraction decrement from baseline was detected without any clinical sign of heart failure. CONCLUSIONS Our RLP trial included only visceral metastatic, trastuzumab-naïve BC patients including cases with brain involvement who received PTT combination in the first-line treatment. Regardless of negative prognostic characteristics, our results are in parallel with pivotal trial. Further strategies for brain metastasis should be developed to improve outcomes despite encouraging results with PTT treatment. Taxane selection can be personalized and endocrine maintenance may further improve outcomes after taxanes were discontinued. To our knowledge, this is the largest scale real-life clinical practice study of pertuzumab-trastuzumab-taxane therapy to date.
Collapse
MESH Headings
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized/administration & dosage
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Breast Neoplasms/drug therapy
- Breast Neoplasms/mortality
- Breast Neoplasms/pathology
- Carcinoma, Ductal, Breast/drug therapy
- Carcinoma, Ductal, Breast/mortality
- Carcinoma, Ductal, Breast/secondary
- Carcinoma, Lobular/drug therapy
- Carcinoma, Lobular/mortality
- Carcinoma, Lobular/secondary
- Docetaxel/administration & dosage
- Female
- Follow-Up Studies
- Humans
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Metastasis
- Paclitaxel/administration & dosage
- Practice Patterns, Physicians'
- Prognosis
- Retrospective Studies
- Survival Rate
- Trastuzumab/administration & dosage
- Young Adult
Collapse
Affiliation(s)
- Ece Esin
- Department of Medical Oncology, Dr. A. Y. Ankara Oncology Education and Research Hospital, University of Health Sciences, Yenimahalle, Ankara, Turkey.
| | - B Oksuzoglu
- Department of Medical Oncology, Dr. A. Y. Ankara Oncology Education and Research Hospital, University of Health Sciences, Yenimahalle, Ankara, Turkey
| | - A Bilici
- Departmant of Medical Oncology, Medipol University International Health Center, Istanbul, Turkey
| | - I Cicin
- Department of Medical Oncology, Trakya University, Edirne, Turkey
| | - O Kostek
- Department of Medical Oncology, Trakya University, Edirne, Turkey
| | - M A Kaplan
- Department of Medical Oncology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
| | - S Aksoy
- Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
| | - B Y Aktas
- Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
| | - O Ozdemir
- Department of Medical Oncology, Ataturk Education and Research Hospital, İzmir K.C. University, Izmir, Turkey
| | - A Alacacioglu
- Department of Medical Oncology, Ataturk Education and Research Hospital, İzmir K.C. University, Izmir, Turkey
| | - D Cabuk
- Department of Medical Oncology, Faculty of Medicine, Kocaeli University, Izmit, Turkey
| | - A T Sumbul
- Department of Medical Oncology, Baskent University Adana Hospital, Adana, Turkey
| | - A Sakin
- Department of Medical Oncology, Istanbul Okmeydani Education and Research Hospital, Istanbul, Turkey
| | - S Paydas
- Department of Medical Oncology, Faculty of Medicine, Cukurova University, Adana, Turkey
| | - E Yetisir
- Department of Medical Oncology, Faculty of Medicine, Cukurova University, Adana, Turkey
| | - O Er
- Department of Medical Oncology, Acibadem Maslak Hospital, Acibadem MAA University, Istanbul, Turkey
| | - T Korkmaz
- Department of Medical Oncology, Acibadem Altunizade Hospital, Acibadem MAA University, Istanbul, Turkey
| | - N Yildirim
- Department of Medical Oncology, Dr. Ersin Arslan Training and Research Hospital, Gaziantep, Turkey
| | - T Sakalar
- Department of Medical Oncology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
| | - H Demir
- Department of Medical Oncology, Kayseri Education and Research Hospital, University of Health Sciences, Kayseri, Turkey
| | - M Artac
- Department of Medical Oncology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey
| | - M Karaagac
- Department of Medical Oncology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey
| | - H Harputluoglu
- Department of Medical Oncology, Turgut Ozal Medical Center, Inonu University, Malatya, Turkey
| | - E Bilen
- Department of Medical Oncology, Turgut Ozal Medical Center, Inonu University, Malatya, Turkey
| | - E Erdur
- Department of Medical Oncology, Dr. A. Y. Ankara Oncology Education and Research Hospital, University of Health Sciences, Yenimahalle, Ankara, Turkey
| | - S Degirmencioglu
- Department of Medical Oncology, Faculty of Medicine, Pamukkale University, Denizli, Turkey
| | - A Aliyev
- Department of Medical Oncology, Faculty of Medicine, Bezmialem University, Istanbul, Turkey
| | - T Cil
- Department of Medical Oncology, Adana City Hospital, University of Health Sciences, Adana, Turkey
| | - P Olgun
- Department of Medical Oncology, Adana City Hospital, University of Health Sciences, Adana, Turkey
| | - G Basaran
- Department of Medical Oncology, Acibadem Maslak Hospital, Acibadem MAA University, Istanbul, Turkey
| | - O Gumusay
- Department of Medical Oncology, Faculty of Medicine, Gaziosmanpasa University, Tokat, Turkey
| | - A Demir
- Department of Medical Oncology, Istanbul Okmeydani Education and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - E Tanrikulu
- Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey
| | - P F Yumuk
- Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey
| | - Inanc Imamoglu
- Department of Medical Oncology, Ankara Diskapi Education and Research Hospital, University of Health Sciences, Ankara, Turkey
| | - B Oyan
- Department of Medical Oncology, Acibadem Altunizade Hospital, Acibadem MAA University, Istanbul, Turkey
| | - B Cetin
- Department of Medical Oncology, Faculty of Medicine, RTE University, Rize, Turkey
| | - V Haksoyler
- Department of Medical Oncology, Diyarbakir G.Y. Education and Research Hospital, University of Health Sciences, Diyarbakir, Turkey
| | - N Karadurmus
- Department of Medical Oncology, Gulhane Education and Research Hospital, University of Health Sciences, Ankara, Turkey
| | - I Erturk
- Department of Medical Oncology, Gulhane Education and Research Hospital, University of Health Sciences, Ankara, Turkey
| | - T Evrensel
- Department of Medical Oncology, Faculty of Medicine, Uludag University, Bursa, Turkey
| | - H Yilmaz
- Department of Medical Oncology, Faculty of Medicine, Uludag University, Bursa, Turkey
| | - I Beypinar
- Department of Medical Oncology, Faculty of Medicine, Afyon Kocatepe University, Afyon, Turkey
| | - M Kocer
- Department of Medical Oncology, Faculty of Medicine, Isparta S.D University, Isparta, Turkey
| | - K N Pilanci
- Department of Medical Oncology, Haseki Education and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - M Seker
- Department of Medical Oncology, Ankara Bayindir Hospital, Ankara, Turkey
| | - Y Urun
- Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey
| | - N Yildirim
- Department of Medical Oncology, Numune Education and Research Hospital, University of Health Sciences, Ankara, Turkey
| | - T Eren
- Department of Medical Oncology, Numune Education and Research Hospital, University of Health Sciences, Ankara, Turkey
| | - U Demirci
- Department of Medical Oncology, Dr. A. Y. Ankara Oncology Education and Research Hospital, University of Health Sciences, Yenimahalle, Ankara, Turkey
| |
Collapse
|
4
|
Kasapkara HA, Şentürk A, Bilen E, Duran Karaduman B, Ayhan H, Özen MB, Durmaz T, Keleş T, Bozkurt E. The usefulness of left atrial volume index and left ventricular mass index in determining subclinical cardiac involvement in patients with early-stage sarcoidosis. Ir J Med Sci 2015; 185:617-621. [PMID: 26023058 DOI: 10.1007/s11845-015-1318-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2015] [Accepted: 05/23/2015] [Indexed: 11/24/2022]
Abstract
BACKGROUND AND AIM Sarcoidosis is a multi-systemic granulomatous disease of unknown etiology. The present study has been designed to evaluate the importance of diastolic dysfunction with left atrial volume index (LAVi) and left ventricular mass index (LVMi) in determining subclinical cardiac involvement in subjects with stage I-II pulmonary sarcoidosis. METHODS A total of 54 patients under follow-up for sarcoidosis without cardiac involvement and 56 healthy subjects were included in the study. The echocardiographic assessment of the patients revealed no significant difference between the two groups regarding left ventricular end-systolic and end-diastolic diameters, ejection fraction (LVEF) and annular velocity determined by tissue Doppler evaluation. RESULTS The LVEF calculated was 61.8 ± 7.8 % in the sarcoidosis group versus 64.1 ± 2.7 % in the control group (p = 0.04). Left ventricular interventricular septum thickness, posterior wall thickness, and relative wall thickness were significantly higher in the sarcoidosis group compared to the control group (p < 0.001). The sarcoidosis group had higher LVM and LVMi values compared to the control group (145 ± 18.1 and 79 ± 14 g/m(2), 135 ± 27.7 and 74 ± 14.2 g/m(2); p = 0.020 and p = 0.021, respectively). Left atrial end-systolic volume and LAVi were higher in the sarcoidosis group (28.7 ± 18.5; 15.6 ± 10.2) compared to the control group (16.6 ± 10.9; 8.9 ± 5.5) with a statistically significant difference (p < 0.001). CONCLUSION The present study indicates diastolic dysfunction and increased LVMi despite normal systolic function in patients with early-stage sarcoidosis without cardiac involvement. Also, the diastolic parameters were normal without showing any significant difference compared to the control group while there was a statistically significant increase in LAVi. This finding suggests that LAVi may be the earliest marker of diastolic dysfunction in patients with early-stage sarcoidosis without cardiac involvement.
Collapse
Affiliation(s)
- H A Kasapkara
- Faculty of Medicine, Department of Cardiology, Yıldırım Beyazıt University, Ankara, Turkey
| | - A Şentürk
- Department of Pulmonary Diseases, Ankara Ataturk Education and Research Hospital, Ankara, Turkey
| | - E Bilen
- Department of Cardiology, Ankara Ataturk Education and Research Hospital, Bilkent, 06800, Ankara, Turkey
| | - B Duran Karaduman
- Department of Cardiology, Ankara Ataturk Education and Research Hospital, Bilkent, 06800, Ankara, Turkey
| | - H Ayhan
- Faculty of Medicine, Department of Cardiology, Yıldırım Beyazıt University, Ankara, Turkey. .,Department of Cardiology, Ankara Ataturk Education and Research Hospital, Bilkent, 06800, Ankara, Turkey.
| | - M B Özen
- Department of Cardiology, Ankara Ataturk Education and Research Hospital, Bilkent, 06800, Ankara, Turkey
| | - T Durmaz
- Faculty of Medicine, Department of Cardiology, Yıldırım Beyazıt University, Ankara, Turkey
| | - T Keleş
- Faculty of Medicine, Department of Cardiology, Yıldırım Beyazıt University, Ankara, Turkey
| | - E Bozkurt
- Faculty of Medicine, Department of Cardiology, Yıldırım Beyazıt University, Ankara, Turkey
| |
Collapse
|
5
|
Sari C, Ayhan H, Aslan AN, Durmaz T, Keleş T, Baştuğ S, Bayram NA, Bilen E, Kasapkara HA, Bozkurt E. Predictors and incidence of access site complications in transcatheter aortic valve implantation with the use of new delivery systems. Perfusion 2015; 30:666-74. [DOI: 10.1177/0267659115578002] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Objectives: The aim of this single-center study was to assess the incidence and predictors of in-hospital access site complications related to transcatheter aortic valve implantation (TAVI) performed with new delivery systems in our hospital which has the largest case series in Turkey. Materials and method: We performed successful TAVI with the Edwards Sapien XT valve to 127 (46 male) patients via a transfemoral (121), trans-subclavian (5) and transapical (1) approach. Access site complications were defined according to the Valve Academic Research Consortium (VARC) end-point definitions. Results: Vascular complications occurred in 10.1% of patients. There was negative correlation between vascular complications and diameter of the common femoral artery (r = − 0.301, p=0.004), external iliac artery (r = − 0.327, p=0.004) and common iliac artery (r = − 0.324, p=0.004), but positive correlation between diabetes (r =0.240, p=0.008), sheath to femoral artery ratio (SFAR), sheath to external iliac artery ratio (SEIAR), procedure time, discharge time and the Society of Thoracic Surgeons (STS) score (respectively; r=0.339, 0.001, 0.527, 0.361, 0.289, p=0.003, 0.001, 0.001, 0.001, 0.002). The incidence of vascular complications was significantly higher in patients with diabetes and a high STS score. VARC bleeding complications occurred in 11.7 % of patients. The learning curve pointing out the importance of experience was significantly important in decreasing both bleeding and vascular complications. Conclusions: In this study, we demonstrated that major vascular complications related to TAVI decrease with the use of smaller delivery systems and experience and increase with high-risk scores (STS) and the presence of diabetes. In addition, VARC major vascular complications, observed mostly in patients with diabete mellitus (DM) and high STS scores, were associated with vascular diameters. These results further underline the importance of experience and a multidisciplinary team in patient selection and management for TAVI.
Collapse
Affiliation(s)
- C Sari
- Department of Cardiology, Ataturk Research and Training Hospital, Ankara, Turkey
| | - H Ayhan
- Cardiology Department, Yıldırım Beyazıt University, Ankara, Turkey
| | - AN Aslan
- Department of Cardiology, Ataturk Research and Training Hospital, Ankara, Turkey
| | - T Durmaz
- Cardiology Department, Yıldırım Beyazıt University, Ankara, Turkey
| | - T Keleş
- Cardiology Department, Yıldırım Beyazıt University, Ankara, Turkey
| | - S Baştuğ
- Department of Cardiology, Ataturk Research and Training Hospital, Ankara, Turkey
| | - N Akar Bayram
- Cardiology Department, Yıldırım Beyazıt University, Ankara, Turkey
| | - E Bilen
- Department of Cardiology, Ataturk Research and Training Hospital, Ankara, Turkey
| | - HA Kasapkara
- Cardiology Department, Yıldırım Beyazıt University, Ankara, Turkey
| | - E Bozkurt
- Cardiology Department, Yıldırım Beyazıt University, Ankara, Turkey
| |
Collapse
|
6
|
Bozkurt E, Sari C, Keles T, Durmaz T, Aslan A, Bastug S, Akar Bayram N, Akcay M, Ayhan H, Kasapkara H, Bilen E. Transfemoral balloon expandable aortic valve implantation on a patient with chronic lymphocytic leukemia following mitral valve prosthesis. Minerva Cardioangiol 2014; 62:501-504. [PMID: 25420504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Affiliation(s)
- E Bozkurt
- Yıldırım Beyazıt University, Cardiology Department, Ankara, Turkey:2 Department of Cardiology, Ataturk Research and Training Hospital, Ankara, Turkey -
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Ayhan H, Durmaz T, Keleş T, Bayram NA, Bilen E, Akçay M, Ersoy R, Bozkurt E. The relationship between acute coronary syndrome and stress hyperglycemia. Exp Clin Endocrinol Diabetes 2014; 122:222-6. [PMID: 24771010 DOI: 10.1055/s-0034-1367002] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
BACKGROUND AND OBJECTIVE Hyperglycemia on admission is associated with increased mortality and morbidity in acute coronary syndrome (ACS) irrespective of presence of diabetes mellitus. To the best of our knowledge, no evidence on the relationship between stress hyperglycemia (SH) and the extent of coronary artery disease is found in the literature. Our objective in this study is to assess the relationship of SH with the prognosis of acute coronary syndrome, extent of coronary artery disease (CAD), development of arrhythmia, and major adverse cardiac events. METHOD 89 patients who were hospitalized in the coronary intensive care unit with diagnosis of ACS between January 2010 and June 2010 were enrolled in the study. The patients were separated into 2 groups as having stress hypergly-cemia or not, according to their blood glucose levels on admission. TIMI and GRACE risk scores were obtained and GENSINI scoring was performed to assess CAD extent for all the patients. Major adverse cardiac events (MACE) (death, MI, re-revascularization, stroke) were recorded for all patients while in the hospital and at 1st and 6th months. RESULTS In our study, MACE, GENSINI scores at 6 months and development of in-hospital arrhythmia rates were statistically significantly higher and left ventricular ejection fractions were statistically significantly lower in the group with SH. The association of TIMI, GRACE, GENSINI, New York Heart Association (NYHA) and Killip classifications with blood glucose, fasting blood glucose and HbA1c on admission was confirmed. CONCLUSION Prognostic course happens to be worse and CAD is more extensive in patients with SH. In addition, blood glucose values may have to be estimated lower compared to the samples in the literature, in order to diagnose SH.
Collapse
Affiliation(s)
- H Ayhan
- Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University
| | - T Durmaz
- Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University
| | - T Keleş
- Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University
| | - N A Bayram
- Department of Cardiology, Ankara Ataturk Education and Research Hospital
| | - E Bilen
- Department of Cardiology, Ankara Ataturk Education and Research Hospital
| | - M Akçay
- Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University
| | - R Ersoy
- Department of Endocrinology, Ankara Ataturk Education and Research Hospital
| | - E Bozkurt
- Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University
| |
Collapse
|
8
|
Umul M, Köse SA, Bilen E, Altuncu AG, Oksay T, Güney M. Effect of increasing paternal body mass index on pregnancy and live birth rates in couples undergoing intracytoplasmic sperm injection. Andrologia 2014; 47:360-4. [DOI: 10.1111/and.12272] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/06/2014] [Indexed: 12/19/2022] Open
Affiliation(s)
- M. Umul
- Department of Urology; Faculty of Medicine; Süleyman Demirel University; Isparta Turkey
| | - S. A. Köse
- Department of Obstetrics and Gynecology; Faculty of Medicine; Süleyman Demirel University; Isparta Turkey
| | - E. Bilen
- Department of Obstetrics and Gynecology; Faculty of Medicine; Süleyman Demirel University; Isparta Turkey
| | - A. G. Altuncu
- Department of Obstetrics and Gynecology; Faculty of Medicine; Süleyman Demirel University; Isparta Turkey
| | - T. Oksay
- Department of Urology; Faculty of Medicine; Süleyman Demirel University; Isparta Turkey
| | - M. Güney
- Department of Obstetrics and Gynecology; Faculty of Medicine; Süleyman Demirel University; Isparta Turkey
| |
Collapse
|
9
|
Akçay M, Sari C, Durmaz T, Keles T, Ozen M, Bayram N, Bilen E, Ayhan H, Kasapkara H, Bozkurt E. Transfemoral balloon expandable aortic valve implantation in a patient with myelodysplastic syndrome. Perfusion 2013; 28:409-11. [PMID: 23563894 DOI: 10.1177/0267659113483801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
In this case presentation, the transcatheter aortic valve implantation (TAVI) intervention successfully performed on a 76-year-old male patient with severe degenerative aortic stenosis and diagnosed with myelodysplastic syndrome (MDS) is discussed. This case presentation represents the first case on the treatment of severe aortic stenosis on a patient with myelodysplastic syndrome through the use of the TAVI method and may form an alternative to surgery in patients with severe aortic stenosis who have a known haematological disease. For a successful procedure, the patient must be evaluated in cooperation with the haematology clinic and all necessary precautions regarding bleeding and infection complications of the patient must be taken prior to the procedure.
Collapse
Affiliation(s)
- M Akçay
- Yıldırım Beyazıt University, Cardiology Department, Ankara, Turkey
| | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Bilen E, Akdi A, Tanboga I, Kurt M, Koçak U, Keleş T, Bozkurt E. PP-215 ASSOCIATION OF ADMISSION MEAN PLATELET VOLUME WITH INFARCT RELATED CORONARY ARTERY PATENCY IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION. Int J Cardiol 2012. [DOI: 10.1016/s0167-5273(12)70415-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
11
|
Tanboga I, Kurt M, Bilen E, Ksakal E, Kaya A, Isik T, Ekinci M, Kayin M. OP-131 ASSESSMENT of RIGHT VENTRICULAR MECHANICS IN PATIENTS WITH MITRAL STENOSIS BY TWO-DIMENSIONAL DEFORMATION IMAGING. Int J Cardiol 2012. [DOI: 10.1016/s0167-5273(12)70074-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
12
|
Durmaz T, Keles T, Ayhan H, Cay N, Bilen E, Bayram N, Akcay M, Bozkurt E. OP-074 THE ASSOCIATION BETWEEN PARAOXONASE ACTIVITY AND AORTIC STIFFNESS PARAMETERS. Int J Cardiol 2012. [DOI: 10.1016/s0167-5273(12)70037-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
13
|
Bilen E, Tanboga I, Kurt M, Kocak U, Ayhan H, Keleş T, Bozkurt E. PP-038 MEAN PLATELET VOLUME IS INCREASED IN PATIENTS WITH MYOCARDIAL BRIDGE. Int J Cardiol 2012. [DOI: 10.1016/s0167-5273(12)70271-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Bilen E, Yaşar A, Bilge M, Yüksel I, Aslantaş U, Kurt M, Ipek G, Karakaş M, Tanboga I. PP-070 EFFECT OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION ON MYOCARDIAL REPOLARIZATION. Int J Cardiol 2012. [DOI: 10.1016/s0167-5273(12)70295-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
15
|
Karakaş M, Bilen E, Kurt M, Arslantaş U, Ipek G, Karakaş E, Yüksel I, Yaşar A, Bilge M. PP-053 THE CORRELATION BETWEEN INFARCT SIZE AND THE QRS AXIS CHANGE AFTER THROMBOLYTIC THERAPY IN ST ELEVATION ACUTE MYOCARDIAL INFARCTION. Int J Cardiol 2012. [DOI: 10.1016/s0167-5273(12)70286-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
16
|
Kurt M, Tanboga I, Bilen E, Işık T, Kaya A, Aksakal E, Sevimli S, Açıkel M. PP-006 DOES EXTREMELY HIGH HDL-CHOLESTEROL LEVEL PROTECT AGAINST TO ATHEROSCLEROSIS? Int J Cardiol 2012. [DOI: 10.1016/s0167-5273(12)70244-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
17
|
Isik T, Uyarel H, Bilen E, Ayhan E, Gunaydin Z, Kaya A, Tanboga I, Poyraz E, Kurt M, Ulusoy F, Ekinci M, Ergelen M. OP-147 RELATION OF RED CELL DISTRIBUTION WIDTH WITH PRESENCE AND SEVERITY OF ISOLATED CORONARY ARTERY ECTASIA. Int J Cardiol 2012. [DOI: 10.1016/s0167-5273(12)70088-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
18
|
Ayhan H, Keles T, Bayram N, Bilen E, Durmaz T, Akçay M, Sari C, Bozkurt E. OP-276 IS THERE ASSOCIATION BETWEEN ACUTE CORONARY SYNDROMES AND LEVELS OF PROSTATE SPESIFIC ANTIGEN. Int J Cardiol 2012. [DOI: 10.1016/s0167-5273(12)70179-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
19
|
Bilen E, Kurt M, Tanboga I, Koçak U, Ayhan H, Durmaz T, Bozkurt E. OP-032 ASSESSMENT OF PHASIC LEFT ATRIAL FUNCTIONS IN HEART FAILURE PATIENTS WITH PRESERVED AND LOW EJECTION FRACTION. Int J Cardiol 2012. [DOI: 10.1016/s0167-5273(12)70018-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
20
|
Akar Bayram N, Bozkurt E, Ayhan H, Gürkaş E, Orhan G, Ak F, Bilen E, Sari C, Akçay M, Durmaz T, Keles T. Early outcomes of carotid artery stenting. Perfusion 2012; 27:146-9. [PMID: 22249963 DOI: 10.1177/0267659111431759] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
BACKGROUND AND AIM Ischemic cerebrovascular events are the most common reason for patients to be bedridden and the third most common reason for death. Many studies in recent years have demonstrated that carotid artery stenting (CAS) may be an alternative to carotid endarterectomy (CEA). In this study, we aimed to report early outcomes of patients who were treated with CAS in our clinic and discuss practicability, advantages and safety of CAS. METHODS AND FINDINGS Eighty patients who underwent CAS between December 2009 and May 2011 were eligible. The mean age was 65 years (range, 49 - 89 years). Of the study group, 73.75% were males and 26.25% were female. The percentage of asymptomatic patients was 11.7%, and the remaining patients were symptomatic. A distal embolic protection device (Angioguard®) was used in 22% of the patients whereas, in the other patients (78%), a proximal blockage system (Mo.MA®) was used. Self-expandable hybrid stents were implanted in all patients and post-dilatation was performed after implantation. None of the patients suffered from stroke, myocardial infarction or death due to CAS during their hospital stay. The mean follow-up period was 10 months (range 2 - 18 months) after discharge. None of the patients had died or had a stroke, a transient ischemic attack (TIA), or a myocardial infarction during the follow-up period. Re-stenosis was not observed in the follow-up carotid Doppler ultrasonography; flow rates were within normal limits. CONCLUSION No major complication was observed during the early follow-up period in patients who underwent CAS in our clinic. Only 2 (2.5%) patients showed transient numbness and weakness and these did not lead to morbidity. In the management guide of extracranial carotid and vertebral artery diseases, CAS, in the light of recent studies, is recommended as an alternative to CEA in recommendations for revascularization. One of the important issues emphasized in this guide is the experience of centers. Very low complication rates after CAS suggested that, with suitable patient selection and an experienced team, similar results may be obtained.
Collapse
Affiliation(s)
- N Akar Bayram
- Cardiology Clinics, Ankara Atatürk Education and Research Hospital, Ankara, Turkey.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Kurt M, Tanboga IH, Aksakal E, Kaya A, Isik T, Ekinci M, Bilen E. Relation of left ventricular end-diastolic pressure and N-terminal pro-brain natriuretic peptide level with left atrial deformation parameters. Eur Heart J Cardiovasc Imaging 2011; 13:524-30. [DOI: 10.1093/ejechocard/jer283] [Citation(s) in RCA: 59] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
22
|
Kurt M, Isik T, Kaya A, Ekinci M, Bilen E, Simsek Z, Bayram E, Tanboga I. OP-085: TRANSESOPHAGEAL 2-DIMENSIONAL SPECKLE TRACKING ECHOCARDIOGRAPHY: DEFINITION NORMAL RANGE. Int J Cardiol 2011. [DOI: 10.1016/s0167-5273(11)70171-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
23
|
Bilen E, Kurt M, Isik T, Ekinci M, Kaya A, Bayram E, Simsek Z, Tanboga I. PP-115: SEVERITY OF MITRAL STENOSIS AND LEFT VENTRICULAR MECHANICS: A SPECKLE TRACKING STUDY. Int J Cardiol 2011. [DOI: 10.1016/s0167-5273(11)70355-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
24
|
Ekinci M, Kurt M, Kaya A, Isik T, Bilen E, Simsek Z, Tas M, Bayram E, Tanboga I. OP-039: RELATION BETWEEN EPICARDIAL FAT TISSUE ASSESSED BY ECHOCARDIOGRAPHY AND ATRIAL FIBRILLATION. Int J Cardiol 2011. [DOI: 10.1016/s0167-5273(11)70146-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
25
|
Kurt M, Kaya A, Ekinci M, Isik T, Bilen E, Simsek Z, Bayram E, Tanboga I, Tas M. OP-180: COMPARISON OF AORTIC ELASTICITY BY TRANSESOPHAGEAL AND TRANSTHORACIC ECHOCARDIOGRAPHY. Int J Cardiol 2011. [DOI: 10.1016/s0167-5273(11)70222-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
26
|
Sari C, Bayram NA, Bilen E, Bastug S, Sari SO, Ayhan H, Ersoy O, Bozkurt E. PP-005: ASSESSMENT OF LEFT VENTRICULAR FUNCTION BY STRAIN-STRAIN RATE ECHOCARDIOGRAPHY IN PATIENTS WITH CELIAC DISEASE. Int J Cardiol 2011. [DOI: 10.1016/s0167-5273(11)70292-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|